Zobrazeno 1 - 10
of 440
pro vyhledávání: '"Akshay S, Desai"'
Autor:
Jawad H. Butt, Kirsty McDowell, Toru Kondo, Akshay S. Desai, Martin P. Lefkowitz, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Jean L. Rouleau, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Lars Køber, Scott Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 65-77 (2024)
Abstract Aims Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about its prognostic significance in HF with preserved
Externí odkaz:
https://doaj.org/article/cc3942df190d4a5ebb48c652a5cce4f4
Autor:
Natasha L. Patel‐Murray, Luqing Zhang, Brian L. Claggett, Dongchu Xu, Pablo Serrano‐Fernandez, Margaret Healey, Simon Wandel, Chien‐Wei Chen, Jaison Jacob, Huilei Xu, Gordon M. Turner, William Chutkow, Denise P. Yates, Christopher J. O'Donnell, Margaret F. Prescott, Martin Lefkowitz, Claudio R. Gimpelewicz, Michael T. Beste, Faye Zhao, Liangke Gou, Akshay S. Desai, Pardeep S. Jhund, Milton Packer, Marc A. Pfeffer, Margaret M. Redfield, Jean L. Rouleau, Faiez Zannad, Michael R. Zile, John J. V. McMurray, Michael M. Mendelson, Scott D. Solomon, Jonathan W. Cunningham
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 13 (2024)
Background Prognostic markers and biological pathways linked to detrimental clinical outcomes in heart failure with preserved ejection fraction (HFpEF) remain incompletely defined. Methods and Results We measured serum levels of 4123 unique proteins
Externí odkaz:
https://doaj.org/article/e39880796038474e881ba373a0b6c360
Autor:
Hanna-Riikka Lehto, MD, PhD, Yidi Wang, MD, PhD, Katharine A. Manning, MD, MBE, Joshua R. Lakin, MD, Lauren K. O’Shea, CNP, Michael J. Landzberg, MD, Ariela R. Orkaby, MD, MPH, Akshay S. Desai, MD, MPH, James A. Tulsky, MD, Nelia Jain, MD,MA, Rachelle E. Bernacki, MD, MSc
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100092- (2024)
Background: Patients undergoing evaluation for advanced heart failure therapies (AHT) are at a critical juncture of their illness. Guidelines recommend shared decision-making with patients and caregivers; however, the approach and content of these di
Externí odkaz:
https://doaj.org/article/b5295632a328460c8013bae357f4b198
Autor:
Ankeet S. Bhatt, Muthiah Vaduganathan, Brian L. Claggett, Ian J. Kulac, Inder S. Anand, Akshay S. Desai, James C. Fang, Adrian F. Hernandez, Pardeep S. Jhund, Mikhail N. Kosiborod, Marc S. Sabatine, Sanjiv J. Shah, Orly Vardeny, John J. V. McMurray, Scott D. Solomon, Thomas A. Gaziano
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background The sodium glucose cotransporter‐2 inhibitors are guideline‐recommended to treat heart failure across the spectrum of left ventricular ejection fraction; however, economic evaluations of adding sodium glucose cotransporter‐2 inhibito
Externí odkaz:
https://doaj.org/article/53dbb9210acf48109e85b415aa980e57
Autor:
Ariela R Orkaby, Michael J Landzberg, Rachelle E Bernacki, Hanna-Riikka Lehto, Nelia Jain, Akshay S Desai
Publikováno v:
BMJ Open Quality, Vol 12, Iss 4 (2023)
Background Frailty is common among patients with advanced heart failure (HF), and screening for frailty to guide care is recommended. Although multiple tools are available to screen for frailty, the feasibility of routinely incorporating frailty scre
Externí odkaz:
https://doaj.org/article/a14b8d71d9eb464eab99308bdb546946
Autor:
Jean‐Claude Tardif, Jean Rouleau, Glenn M. Chertow, Ayman Al‐Shurbaji, Vera Lisovskaja, Stephanie Gustavson, Yanli Zhao, Nadia Bouabdallaoui, Akshay S. Desai, Alexander Chernyavskiy, Maria Evsina, Béla Merkely, John J.V. McMurray, Marc A. Pfeffer
Publikováno v:
ESC Heart Failure, Vol 10, Iss 2, Pp 1066-1076 (2023)
Abstract Aims Several patients with heart failure and reduced ejection fraction (HFrEF) do not receive renin–angiotensin–aldosterone system (RAAS) inhibitors at the recommended dose or at all, frequently due to actual or feared hyperkalaemia. Sod
Externí odkaz:
https://doaj.org/article/3f9decbc19424144b1f6cdc8f26cf6c0
Autor:
Nicholas Harrington, Quan M. Bui, Zhe Wei, Brandon Hernandez-Pacheco, Pamela N. DeYoung, Andrew Wassell, Bayan Duwaik, Akshay S. Desai, Deepak L. Bhatt, Parag Agnihotri, Robert L. Owens, Todd P. Coleman, Kevin R. King
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Home health monitoring has the potential to improve outpatient management of chronic cardiopulmonary diseases such as heart failure. However, it is often limited by the need for adherence to self-measurement, charging and self-application of
Externí odkaz:
https://doaj.org/article/05be54c7578140a9a851554c85a012d2
Autor:
Corrado De Marco, Brian L. Claggett, Simon deDenus, Michael R. Zile, Thao Huynh, Akshay S. Desai, Martin G. Sirois, Scott D. Solomon, Bertram Pitt, Jean L. Rouleau, Marc A. Pfeffer, Eileen O'Meara
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1130-1138 (2021)
Abstract Aims Diabetes mellitus (DM) is common in heart failure with preserved ejection fraction (HFpEF). Patients with DM and heart failure with reduced ejection fraction have higher levels of cardiac, profibrotic, and proinflammatory biomarkers rel
Externí odkaz:
https://doaj.org/article/b070388439fb4ff99e7b2abea15e1756
Autor:
Su E. Yeoh, Pooja Dewan, Akshay S. Desai, Scott D. Solomon, Jean L. Rouleau, Marty Lefkowitz, Adel Rizkala, Karl Swedberg, Michael R. Zile, Pardeep S. Jhund, Milton Packer, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3355-3364 (2020)
Abstract Aims Little is known about patient characteristics, outcomes, and the effect of treatment in relation to duration of heart failure (HF). We have investigated these questions in PARADIGM‐HF. The aim of the study was to compare patient chara
Externí odkaz:
https://doaj.org/article/6b9cd33b5f4844ebbfd23120209dea3b
Autor:
Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin P. Lefkowitz, Michael R. Zile, Dirk J. Van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo P. Maggioni, Michele Senni, Brian L. Claggett, Scott D. Solomon, John J. V. McMurray
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserve
Externí odkaz:
https://doaj.org/article/88441a2adc5146caaed5c0a4cbd5ced4